US Patent 10272051 Method to treat atopic dermatitis
Patent 10272051 was granted and assigned to AXIM Biotechnologies on April, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+460 characters)
Article
Patent abstract
A method to treat the skin condition atopic dermatitis is described in this invention. The method comprises topical application of a composition containing cannabinoids, specifically cannabidiol and cannabigerol at a concentration of 3%-20% by weight of the composition. The method may further comprise administering chewing gum containing cannabinoids such as cannabidiol. Cannabidiol and cannabigerol may be sourced naturally or synthetically.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
George Anastassov0
Lekhram Changoer0
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 26 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10272051 Method to treat atopic dermatitis
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10272051
Date of patent
April 30, 2019
Patent application number
16106524
Date Filed
August 21, 2018
Patent primary examiner
Find more entities like US Patent 10272051 Method to treat atopic dermatitis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.